Amyloidosis is a disease characterized by depositions of amyloid in organs and tissues. It
can be localized (in just one organ) or systemic. Cardiac amyloidosis is a debilitating …

Myocardial assessment continues to be an issue in patients with coronary artery disease
and left ventricular dysfunction. Nuclear imaging has long played an important role in this …

Introduction In normal condition, the heart obtains more than two-thirds of its energy from the
oxidative metabolism of long chain fatty acids, although a wide variety of substrates such as …

Fatty acid oxidation is the most efficient mode of myocardial energy production which
requires a large amount of oxygen. Thus, alteration of fatty acid oxidation is considered to be …

Abstract 123 I-labeled 15-(p-iodophenyl)-3R, S-methyl pentadecanoic acid (BMIPP) is a
branched-chain free fatty acid that is used to evaluate various cardiac diseases. The aim of …

Background We conducted a systematic review to summarize the current literature on the
prognostic value of BMIPP imaging, fatty-acid metabolic imaging, for the prediction of …

Objectives: The aim of this study was to assess the prognostic value of the amount of
perfusion-metabolic mismatch in revascularized patients with left ventricular (LV) dysfunction …

Heart failure remains a major cause of morbidity and mortality in the Western world, with
coronary artery disease (CAD) accounting for around 70% of cases. 1 The identification of …

Purpose Long-chain fatty acid (LCFA) is the main energy source for normal myocardium at
rest, but in ischemic myocardium, the main energy substrate shifts from LCFA to glucose …

In patients with ischemic heart disease detection of myocardial viability is of major clinical
and prognostic importance and may significantly affect therapeutic decisions. Reversible left …